Healthcare Select Sector SPDR (XLV) 72.50

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthcare Select Sector SPDR (XLV) 72.50 $XLV

Healthcare ETFs Rally on Monday Merger Mania - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Mar 31, 9:20AM CDT
The flurry of deals sent the healthcare ETFs higher, reversing the losses resulting from the biotech meltdown last week.
BBP: 31.04 (-0.49), IHF: 133.06 (-1.07), SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), UNH: 118.29 (-2.71), XPH: 123.52 (-1.47), ASPX: 100.27 (-0.09), TEVA: 62.30 (-0.22), DGRS: 30.12 (-0.14), IRY: 51.69 (-0.84), VHT: 135.52 (-1.73), XLV: 72.50 (-1.28)

Worst Revenue And Earnings Declines Since Crisis Year 2009
Wolf Richter - at Seeking Alpha - Mon Mar 30, 8:16AM CDT
Stocks have soared. But despite maxed-out financial engineering and ceaseless Wall-Street hype, the first half is shaping up to be tough. Week after week, corporations and analysts have been whittling down their estimates. By now, revenues of the...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

Which Is Better: Cap-Weighting Or Equal-Weighting?
John Dowdee - at Seeking Alpha - Fri Mar 27, 3:56PM CDT

RYH: 155.22 (-2.05), RTM: 85.63 (-0.82), XLB: 48.78 (-0.49), RSP: 81.05 (-0.56), XLY: 75.35 (-0.33), XLU: 44.43 (+0.01), RYT: 91.90 (-0.69), XLV: 72.50 (-1.28), RYU: 74.25 (-0.30), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), RGI: 89.89 (-0.50), XLK: 41.44 (-0.43), RCD: 91.64 (-0.03), XLI: 55.77 (-0.56), RHS: 107.94 (-0.87), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), XLE: 77.58 (-0.46)

Biotech’s Busted — Here’s What To Do Now…
Greg Guenthner - Daily Reckoning - Fri Mar 27, 10:41AM CDT
This post Biotech’s Busted — Here’s What To Do Now… appeared first on Daily Reckoning . Biotechs blasted lower all week. Semiconductors hit the mat. And the once high-flying Nasdaq lost more than 3% as of yesterday—topping off its worst...
IBB: 343.43 (-7.89), IWM: 124.37 (-0.40), XLV: 72.50 (-1.28)

Market Trend Analysis By Comparing Equal Weight To Market Weight Indexes
Richard Shaw - Seeking Alpha - Fri Mar 27, 10:20AM CDT
As a generality, a healthy stock market up trend has broad participation in the trend by a large or increasing portion of its constituents; and conversely an unhealthy market has a low or declining portion of it constituents participating in an up...
RYH: 155.22 (-2.05), XLB: 48.78 (-0.49), RTM: 85.63 (-0.82), RSP: 81.05 (-0.56), EWRS: 46.25 (+0.14), XLY: 75.35 (-0.33), QQEW: 43.80 (-0.43), XLU: 44.43 (+0.01), RYT: 91.90 (-0.69), XLV: 72.50 (-1.28), RYU: 74.25 (-0.30), IWB: 115.85 (-1.01), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), RGI: 89.89 (-0.50), XLK: 41.44 (-0.43), RCD: 91.64 (-0.03), XLI: 55.77 (-0.56), RHS: 107.94 (-0.87), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), XLE: 77.58 (-0.46), EWRI: 52.09 (-0.34)

My 2015 Select Sector SPDR ETFs Algorithmic Forecast And Allocation
I Know First Research - at Seeking Alpha - Thu Mar 26, 11:52AM CDT

XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), IPS: 40.21 (-0.64), XLK: 41.44 (-0.43), IPW: 19.34 (-0.22), XLF: 24.11 (-0.17), IPK: 33.57 (-0.39), IRY: 51.69 (-0.84), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

The Future's Not Over Yet: A Retrospective On Peter Thiel's 2011 Predictions
Noise Dampener - at Seeking Alpha - Wed Mar 25, 1:28AM CDT
Peter Thiel is unique among Silicon Valley gurus in terms of his entrepreneurial success, as well as his libertarian political leanings. Part of his motivation for co-founding PayPal was to protect people in developing countries from the "fast...
XTN: 106.31 (-0.63), VFH: 49.28 (-0.29), XLF: 24.11 (-0.17), IYT: 156.62 (-0.84), VHT: 135.52 (-1.73), XLV: 72.50 (-1.28)

Why A 'Rate Hike Tantrum' Will Not Kill Bond ETFs In 2015
Gary Gordon - at Seeking Alpha - Tue Mar 24, 5:51PM CDT
The 10-year Treasury note is the most recognizable, and most important, debt instrument in the world's financial system. It is vital to foreign jurisdictions, banks and investors as a way to gain exposure to the U.S. dollar, as well as interest...
TLH: 138.57 (+0.23), IEF: 108.39 (+0.28), EDV: 129.81 (+0.43), VYM: 68.30 (-0.28), USMV: 41.26 (-0.29), TLT: 130.69 (+0.28), XLV: 72.50 (-1.28)

Why Anthem, Inc. Can Continue Outperforming The Health Care Sector
Brian Wu - at Seeking Alpha - Tue Mar 24, 4:09PM CDT

CI: 129.44 (-0.52), ANTM: 154.41 (-2.44), UNH: 118.29 (-2.71), AET: 106.53 (-2.04), XLV: 72.50 (-1.28), HUM: 178.02 (-3.16)

Choosing The Right Healthcare ETF
Matt Erickson - Seeking Alpha - Tue Mar 24, 7:47AM CDT
Not all ETFs are created equal. In many instances, some may be dramatically superior to others, even though offering what on the surface may appear to be the same market exposure. Generally speaking, it pays to be mindful of internal expense ratios,...
RYH: 155.22 (-2.05), FXH: 67.02 (-0.98), XLV: 72.50 (-1.28)

URGENT: Take Profits on These 3 Trades
Greg Guenthner - Daily Reckoning - Mon Mar 23, 8:56AM CDT
This post URGENT: Take Profits on These 3 Trades appeared first on Daily Reckoning . I do not think any of these tickers is headed for a nasty crash right now. But they could pull back a bit more than we'd like. So why stick around when we've...
IBB: 343.43 (-7.89), IWM: 124.37 (-0.40), XLV: 72.50 (-1.28)

Relative Risk Adjusted Return For Retirees And Those Who Prefer A Smoother Ride
Richard Shaw - at Seeking Alpha - Sat Mar 21, 12:17AM CDT

SPYG: 98.59 (-0.94), IYH: 154.32 (-2.24), VDC: 126.99 (-1.00), XLY: 75.35 (-0.33), IYC: 144.20 (-0.74), IBB: 343.43 (-7.89), XLV: 72.50 (-1.28), IVW: 113.95 (-1.10), VUG: 104.61 (-3.93), FVD: 24.09 (-0.13), XLP: 48.74 (-0.46), VCR: 122.48 (-0.43), JKE: 118.24 (-1.42), JKG: 153.73 (-0.62), IWF: 98.92 (-0.86), IXJ: 107.81 (-1.69), VHT: 135.52 (-1.73)

Health Care Select Sector SPDR announces quarterly distribution of $0.208
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 1:21PM CDT

XLV: 72.50 (-1.28)

THQ: This New Healthcare CEF Looks Positioned To Move Higher
Value and Income Insights - at Seeking Alpha - Fri Mar 20, 12:49PM CDT

THQ: 20.58 (-0.08), HQL: 27.57 (-0.30), HQH: 34.85 (-0.18), XLV: 72.50 (-1.28)

What To Expect When The Fed Actually Does Raise Rates
Dirk Leach - at Seeking Alpha - Thu Mar 19, 4:28PM CDT

RYH: 155.22 (-2.05), KXI: 91.57 (-1.30), IYH: 154.32 (-2.24), VDC: 126.99 (-1.00), IPS: 40.21 (-0.64), RXL: 141.39 (-3.75), XLV: 72.50 (-1.28), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), FSTA: 29.56 (-0.22), QQQ: 105.60 (-1.13), DIA: 177.58 (-1.81), FHLC: 35.26 (-0.48), RXD: 12.72 (+0.14), RHS: 107.94 (-0.87), IWM: 124.37 (-0.40), FXG: 44.63 (-0.32), CURE: 147.07 (-6.72), VHT: 135.52 (-1.73), FXH: 67.02 (-0.98)

Investors Should Stick With Health Care Stocks, eBay Has Downside
at The Street - Thu Mar 19, 1:56PM CDT
The CNBC ‘Fast Money Halftime’ trading panel agrees that health care stocks still have an upside, while an analyst explains his decision to downgrade eBay.
KMI: 42.06 (-0.01), BIIB: 422.24 (-9.38), MNST: 138.40 (-2.04), EWG: 29.84 (-0.52), VXX: 25.63 (+0.67), NKE: 100.33 (-0.56), UNH: 118.29 (-2.71), KORS: 65.75 (-0.51), TLT: 130.69 (+0.28), GOOG: 548.00 (-4.03), COH: 41.43 (-0.16), SPY: 206.43 (-1.82), EBAY: 57.68 (-0.24), DIA: 177.58 (-1.81), GOOGL: 554.70 (-6.44), FL: 63.00 (-0.61), FXE: 105.71 (-0.61), AAPL: 124.43 (-1.94), FB: 82.21 (-0.98), TIF: 88.01 (-0.58), XLU: 44.43 (+0.01), UUP: 25.90 (+0.04), XRT: 101.04 (-0.54), ARO: 3.47 (+0.14), XLV: 72.50 (-1.28), CELG: 115.28 (-4.74), GES: 18.59 (-0.30), UA: 80.75 (+0.84), QQQ: 105.60 (-1.13), BONT: 6.96 (-0.02), GILD: 98.13 (-2.56), CRI: 92.47 (+0.63), IWM: 124.37 (-0.40)

Unwinding The Mother Of All Carry Trades?
Leo Kolivakis - Seeking Alpha - Tue Mar 17, 6:43AM CDT
Over the weekend, Mike Whitney wrote an interesting comment for Counterpunch, Why a Stronger Dollar will Lead to Deflation, Recession and Crisis : "There are no nations…. no peoples…. no Russians.. no Arabs…no third...
XLB: 48.78 (-0.49), QQQ: 105.60 (-1.13), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), XLK: 41.44 (-0.43), FXE: 105.71 (-0.61), XLU: 44.43 (+0.01), UUP: 25.90 (+0.04), XLV: 72.50 (-1.28), GSG: 19.50 (-0.24), XLE: 77.58 (-0.46)

Stocks Rebound After Rocky Week As Oil Prices Plummet
at The Street - Mon Mar 16, 3:10PM CDT
Stocks held onto session highs Monday ahead of the Federal Reserve's two-day policy meeting beginning on Tuesday.
NFLX: 416.69 (-5.88), TSLA: 188.77 (-1.80), VRX: 198.62 (-2.76), GE: 24.81 (-0.31), SLXP: 172.81 (+0.16), DIS: 104.89 (-1.23), PG: 81.94 (-0.78), XLV: 72.50 (-1.28), KING: 16.04 (+0.19)

Stocks Extend Session Highs as Wall Street Gears Up For Fed Meeting
at The Street - Mon Mar 16, 2:05PM CDT
Stocks hold onto session highs by midafternoon Monday ahead of the Federal Reserve's two-day policy meeting that begins Tuesday.
BID: 42.26 (-0.14), TSLA: 188.77 (-1.80), GE: 24.81 (-0.31), VRX: 198.62 (-2.76), SLXP: 172.81 (+0.16), DIS: 104.89 (-1.23), XLV: 72.50 (-1.28), NFLX: 416.69 (-5.88), MSG: 84.65 (+0.21), PG: 81.94 (-0.78)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 10

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 11

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 9

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 15

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercury Capital Secures $4.35M Loan for Retail Hub

Updated Category News Views 21

Mercury Capital Partners Banks on Retail Development They say the beauty's in the numbers, but the magic happens when you make those numbers work for you. Mercury Capital Partners (MCP) is wrangling dollars like no one's business, pushing a $4.35 million construction loan into the Fort Myers scene like it's a walk in the park. We're looking at Estero Oaks, a...

Continue Reading
Amazon Analysts Update Forecasts for Upcoming Earnings Report

Updated Category News Views 130

Amazon's Upcoming Earnings Call Amazon.com, Inc. (NASDAQ: AMZN) is set to unveil its earnings results for the second quarter. This announcement will provide valuable insights into the company's financial health and operational performance. Market expectations are leaning toward a positive outlook, as analysts predict robust earnings and revenue growth. Predicted Earnings...

Continue Reading
Understanding the Recent Surge in ServiceNow Options Activity

Updated Category News Views 82

Understanding the Recent Surge in ServiceNow Options Activity Recently, a notable shift occurred in the options market surrounding ServiceNow (NYSE: NOW), drawing attention from both institutional and retail investors. With deep pockets behind these moves, it's crucial to analyze what it could mean for the future of the stock. It’s always intriguing when a significant...

Continue Reading
Join the Exciting Bybit Boost Battle for Weekly USDT Prizes!

Updated Category News Views 176

Join the Exciting Bybit Boost Battle for Weekly USDT Prizes! Bybit, recognized as the second-largest cryptocurrency exchange globally by trading volume, has initiated a vibrant competition called the Boost Battle. This thrilling event allows traders to participate weekly, showcasing their skills and strategies. The grand prize rolls out weekly, presenting winners with the...

Continue Reading
Desert Control's Q2 Progress: Innovations and Financial Insights

Updated Category News Views 190

Desert Control's Q2 2025 Report Summary Desert Control AS (DSRT) has made commendable strides in the second quarter of 2025, revealing significant operational achievements and promising financial results. This report encapsulates the journey and progress of the company, focusing on their innovative solutions that enhance soil health and water conservation. Operational...

Continue Reading